Cargando…

Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development

Peptidomimetics play a fundamental role in drug design due to their preferential properties regarding natural peptides. In particular, compounds possessing nitrogen-containing heterocycles have been intensively studied in recent years. The triazolyl moiety incorporation decreases the molecule suscep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Staśkiewicz, Agnieszka, Ledwoń, Patrycja, Rovero, Paolo, Papini, Anna Maria, Latajka, Rafal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172596/ https://www.ncbi.nlm.nih.gov/pubmed/34095086 http://dx.doi.org/10.3389/fchem.2021.674705

Ejemplares similares

Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation
por: Ledwoń, Patrycja, et al.
Publicado: (2021)

Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy
por: Errante, Fosca, et al.
Publicado: (2020)

Tripeptides conjugated with thiosemicarbazones: new inhibitors of tyrosinase for cosmeceutical use
por: Ledwoń, Patrycja, et al.
Publicado: (2023)

1,4-Disubstituted 1H-1,2,3-Triazole Containing Peptidotriazolamers: A New Class of Peptidomimetics With Interesting Foldamer Properties
por: Schröder, David C., et al.
Publicado: (2019)

Editorial: Peptidomimetics: Synthetic Tools for Drug Discovery and Development
por: Del Gatto, Annarita, et al.
Publicado: (2021)

Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis
por: Staśkiewicz, Agnieszka, et al.
Publicado: (2022)

Design, synthesis, conformational analysis, and biological activity of Cα(1)-to-Cα(6) 1,4- and 4,1-disubstituted 1H-[1,2,3]triazol-1-yl-bridged oxytocin analogues
por: Nuti, Francesca, et al.
Publicado: (2023)

An Optimised Di-Boronate-ChemMatrix Affinity Chromatography to Trap Deoxyfructosylated Peptides as Biomarkers of Glycation
por: Kijewska, Monika, et al.
Publicado: (2020)

Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery
por: Lee, Yeon Sun
Publicado: (2022)

A Photochromic Azobenzene Peptidomimetic of a β-Turn Model Peptide Structure as a Conformational Switch
por: Nuti, Francesca, et al.
Publicado: (2019)

Editorial of Special Column “Novel Peptides and Peptidomimetics in Drug Discovery”
por: Cai, Jianfeng, et al.
Publicado: (2021)

Macrocyclization strategies for cyclic peptides and peptidomimetics
por: Bechtler, Clément, et al.
Publicado: (2021)

Fragment-based drug discovery: opportunities for organic synthesis
por: St. Denis, Jeffrey D., et al.
Publicado: (2020)

Metallodrugs are unique: opportunities and challenges of discovery and development
por: Anthony, Elizabeth J., et al.
Publicado: (2020)

CuAAC-ensembled 1,2,3-triazole-linked isosteres as pharmacophores in drug discovery: review
por: Rani, Alisha, et al.
Publicado: (2020)

Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs
por: Molchanova, Natalia, et al.
Publicado: (2017)

Human defensin-inspired discovery of peptidomimetic antibiotics
por: Luo, Gan, et al.
Publicado: (2022)

The sustainable synthesis of peptidomimetics via chemoenzymatic tandem oxidation–Ugi reaction
por: Madej, Arleta, et al.
Publicado: (2018)

Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators
por: Olson, Keith M., et al.
Publicado: (2021)

Combating amyloid-induced cellular toxicity and stiffness by designer peptidomimetics
por: Konar, Mouli, et al.
Publicado: (2021)

Editor Profiles: Guest Editors of Special Column “Novel Peptides and Peptidomimetics in Drug Discovery”()
Publicado: (2021)

Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites
por: Olaleye, Tayo O., et al.
Publicado: (2014)

G(s) protein peptidomimetics as allosteric modulators of the β(2)-adrenergic receptor
por: Boyhus, Lotte-Emilie, et al.
Publicado: (2018)

Fluorinated triazoles as privileged potential candidates in drug development—focusing on their biological and pharmaceutical properties
por: Ullah, Ihsan, et al.
Publicado: (2022)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

Peptides and Peptidomimetics for Antimicrobial Drug Design
por: Mojsoska, Biljana, et al.
Publicado: (2015)

Controlled inhibition of methyltransferases using photoswitchable peptidomimetics: towards an epigenetic regulation of leukemia
por: Albert, Lea, et al.
Publicado: (2017)

Membrane-Modified Metal Triazole Complexes for the Electrocatalytic Reduction of Oxygen and Carbon Dioxide
por: Supakul, Skye N., et al.
Publicado: (2018)

Covalently attached intercalators restore duplex stability and splice-switching activity to triazole-modified oligonucleotides
por: Dysko, Anna, et al.
Publicado: (2022)

Sub-stoichiometric inhibition of IAPP aggregation: a peptidomimetic approach to anti-amyloid agents
por: Maity, Debabrata, et al.
Publicado: (2020)

Effect of the array of amines on the transfection efficiency of cationic peptidomimetic lipid molecules into neural cells
por: Yu, Xiang, et al.
Publicado: (2022)

Differential copper-guided architectures of amyloid β peptidomimetics modulate oxidation states and catalysis
por: Ghosh, Debasis, et al.
Publicado: (2022)

Discovery of Potent Peptidomimetic Antagonists for Heterochromatin Protein 1 Family Proteins
por: Lamb, Kelsey N., et al.
Publicado: (2021)

Protease inhibitors and their peptidomimetic derivatives as potential drugs
por: Fear, Georgie, et al.
Publicado: (2007)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

A diversity-oriented synthesis strategy enabling the combinatorial-type variation of macrocyclic peptidomimetic scaffolds
por: Isidro-Llobet, Albert, et al.
Publicado: (2015)

Diversity-Oriented Synthesis and Chemoinformatic Analysis of the Molecular Diversity of sp(3)-Rich Morpholine Peptidomimetics
por: Lenci, Elena, et al.
Publicado: (2018)

Traceless solid-phase synthesis and β-turn propensity of 1,3-thiazole-based peptidomimetics
por: Abdildinova, Aizhan, et al.
Publicado: (2021)

Computational insights for predicting the binding and selectivity of peptidomimetic plasmepsin IV inhibitors against cathepsin D
por: Martins, Lucas Sousa, et al.
Publicado: (2022)

Nucleobase-modified nucleosides and nucleotides: Applications in biochemistry, synthetic biology, and drug discovery
por: Berdis, Anthony
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_83bvrabvjgji3uqa01ouibg610